Invasive fungal disease is rare in patients with relapsed/refractory multiple myeloma treated with BCMA CAR T-cell therapy.

Saved in:
Bibliographic Details
Title: Invasive fungal disease is rare in patients with relapsed/refractory multiple myeloma treated with BCMA CAR T-cell therapy.
Authors: Little JS; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Medina Pena A; Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Kim EB; Department of Cellular Immunotherapy, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA., Yee AJ; Department of Cellular Immunotherapy, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA., Nadeem O; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Midha S; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Sperling AS; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Division of Hematology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA., Munshi NC; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Raje N; Department of Cellular Immunotherapy, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA., Frigault MJ; Department of Cellular Immunotherapy, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA., Cirstea DD; Department of Cellular Immunotherapy, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA., Hammond SP; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Department of Cellular Immunotherapy, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.; Division of Infectious Diseases, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
Source: Blood advances [Blood Adv] 2025 Aug 26; Vol. 9 (16), pp. 4190-4194.
Publication Type: Journal Article
Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40561525
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Invasive fungal disease is rare in patients with relapsed/refractory multiple myeloma treated with BCMA CAR T-cell therapy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Little+JS%22">Little JS</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Medina+Pena+A%22">Medina Pena A</searchLink>; Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Kim+EB%22">Kim EB</searchLink>; Department of Cellular Immunotherapy, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Yee+AJ%22">Yee AJ</searchLink>; Department of Cellular Immunotherapy, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Nadeem+O%22">Nadeem O</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Midha+S%22">Midha S</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Sperling+AS%22">Sperling AS</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Division of Hematology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Munshi+NC%22">Munshi NC</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Raje+N%22">Raje N</searchLink>; Department of Cellular Immunotherapy, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Frigault+MJ%22">Frigault MJ</searchLink>; Department of Cellular Immunotherapy, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Cirstea+DD%22">Cirstea DD</searchLink>; Department of Cellular Immunotherapy, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Hammond+SP%22">Hammond SP</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.; Department of Cellular Immunotherapy, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.; Division of Infectious Diseases, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101698425%22">Blood advances</searchLink> [Blood Adv] 2025 Aug 26; Vol. 9 (16), pp. 4190-4194.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Hematology%22">American Society of Hematology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101698425 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2473-9537 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224739529%22">24739529 </searchLink><i>NLM ISO Abbreviation: </i>Blood Adv <i>Subsets: </i>MEDLINE; In Process
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40561525
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1182/bloodadvances.2025016748
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 4190
    Titles:
      – TitleFull: Invasive fungal disease is rare in patients with relapsed/refractory multiple myeloma treated with BCMA CAR T-cell therapy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Little JS
      – PersonEntity:
          Name:
            NameFull: Medina Pena A
      – PersonEntity:
          Name:
            NameFull: Kim EB
      – PersonEntity:
          Name:
            NameFull: Yee AJ
      – PersonEntity:
          Name:
            NameFull: Nadeem O
      – PersonEntity:
          Name:
            NameFull: Midha S
      – PersonEntity:
          Name:
            NameFull: Sperling AS
      – PersonEntity:
          Name:
            NameFull: Munshi NC
      – PersonEntity:
          Name:
            NameFull: Raje N
      – PersonEntity:
          Name:
            NameFull: Frigault MJ
      – PersonEntity:
          Name:
            NameFull: Cirstea DD
      – PersonEntity:
          Name:
            NameFull: Hammond SP
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 26
              M: 08
              Text: 2025 Aug 26
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2473-9537
          Numbering:
            – Type: volume
              Value: 9
            – Type: issue
              Value: 16
          Titles:
            – TitleFull: Blood advances
              Type: main
ResultId 1